ADDXF - Addex Therapeutics Ltd

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 530.51M
Enterprise Value 325.53M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)85.03
Price/Book (mrq)12.08
Enterprise Value/Revenue 371.13
Enterprise Value/EBITDA 6-7.49

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-957.42%

Management Effectiveness

Return on Assets (ttm)-65.89%
Return on Equity (ttm)-193.92%

Income Statement

Revenue (ttm)358.85k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-20.00%
Gross Profit (ttm)-407.59k
Net Income Avi to Common (ttm)-3.49M
Diluted EPS (ttm)-0.2880
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.61M
Total Cash Per Share (mrq)0.27
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.09
Book Value Per Share (mrq)0.18

Cash Flow Statement

Operating Cash Flow (ttm)-2.32M
Levered Free Cash Flow (ttm)-1.24M

Trading Information

Stock Price History

Beta N/A
52-Week Change 318.86%
S&P500 52-Week Change 317.21%
52 Week High 32.4500
52 Week Low 30.0000
50-Day Moving Average 32.2485
200-Day Moving Average 32.3036

Share Statistics

Avg Vol (3 month) 31.62k
Avg Vol (10 day) 36.65k
Shares Outstanding 513.25M
Float 10.76M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A